SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,797,000 | +72.1% | 119,989 | +39.9% | 0.00% | +100.0% |
| Q1 2016 | $1,044,000 | -23.5% | 85,775 | -0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,365,000 | +5.2% | 85,805 | +1.4% | 0.00% | 0.0% |
| Q3 2015 | $1,297,000 | -37.2% | 84,635 | -0.4% | 0.00% | -33.3% |
| Q2 2015 | $2,065,000 | +18.8% | 84,956 | +13.7% | 0.00% | +50.0% |
| Q1 2015 | $1,738,000 | -6.3% | 74,748 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $1,854,000 | -20.4% | 73,846 | -1.4% | 0.00% | -33.3% |
| Q3 2014 | $2,330,000 | +23.3% | 74,914 | +2.6% | 0.00% | 0.0% |
| Q2 2014 | $1,889,000 | +54.8% | 73,037 | +39.9% | 0.00% | +50.0% |
| Q1 2014 | $1,220,000 | -6.4% | 52,212 | +1.6% | 0.00% | 0.0% |
| Q4 2013 | $1,304,000 | +25.6% | 51,384 | +1.0% | 0.00% | 0.0% |
| Q3 2013 | $1,038,000 | +15.6% | 50,882 | +18.8% | 0.00% | 0.0% |
| Q2 2013 | $898,000 | – | 42,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |